Ernexa Therapeutics (ERNAW) Capital Leases (2010 - 2022)
Ernexa Therapeutics (ERNAW) reported Capital Leases of $6000.0 for Q3 2022, up 50.0% quarter-over-quarter from $4000.0 in Q3 2020.
Ernexa Therapeutics (ERNAW) Capital Leases (2010 - 2022) Analysis & Trends
Ernexa Therapeutics has reported Capital Leases for 12 years, with the latest figure at $6000.0 in Q3 2022.
- For the quarter ending Q3 2022, Capital Leases changed N/A year-over-year to $6000.0; the trailing twelve-month figure through Sep 2022 stood at $6000.0 (changed N/A YoY), and the FY2019 full-year result was $20000.0, down 51.22% from the prior year.
- Capital Leases for Q3 2022 stood at $6000.0, up from $4000.0 in the prior quarter.
- The five-year high for Capital Leases was $114000.0 in Q1 2018, with the low at $4000.0 in Q3 2020.
- Historically, Capital Leases has averaged $37300.0 across 4 years, with a median of $28000.0 in 2019.
- Annual changes were most pronounced in 2018 — Capital Leases plunged 48.18% — and 2020, when it slumped 84.0%.
- Ernexa Therapeutics' Capital Leases stood at $41000.0 in 2018, then slumped by 51.22% to $20000.0 in 2019, then tumbled by 80.0% to $4000.0 in 2020, then jumped by 50.0% to $6000.0 in 2022.
- The last three Capital Leases figures came in at $6000.0 (Q3 2022), $4000.0 (Q3 2020), and $15000.0 (Q1 2020), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Ernexa Therapeutics | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 6,000.00 |
| Sep 30, 2020 | 4,000.00 |
| Mar 31, 2020 | 15,000.00 |
| Dec 31, 2019 | 20,000.00 |
| Sep 30, 2019 | 25,000.00 |
| Jun 30, 2019 | 31,000.00 |
| Mar 31, 2019 | 36,000.00 |
| Dec 31, 2018 | 41,000.00 |
| Jun 30, 2018 | 81,000.00 |
| Mar 31, 2018 | 114,000.00 |
| Dec 31, 2017 | 164,000.00 |
| Sep 30, 2017 | 142,000.00 |
| Jun 30, 2017 | 181,000.00 |
| Mar 31, 2017 | 220,000.00 |
| Dec 31, 2016 | 259,000.00 |
| Sep 30, 2016 | 295,000.00 |
| Jun 30, 2016 | 120,000.00 |
| Mar 31, 2016 | 138,000.00 |
| Dec 31, 2015 | 138,000.00 |
| Sep 30, 2015 | 122,000.00 |